Genalyte

Genalyte is pioneering point-of-care diagnostics with its integrated Merlin system, which combines chemistry, hematology, and a proprietary silicon photonics-based immunoassay platform to deliver a broad menu of lab results in approximately 30 minutes. The company targets inefficiencies in traditional laboratory testing, such as patient no-shows, pre-analytical errors, and communication delays, by bringing testing directly into primary care, outpatient, and specialty clinics. While the Merlin platform is not yet commercially available, it represents a significant shift towards decentralized, real-time diagnostics designed to integrate seamlessly with existing electronic medical record systems.

Integrated point-of-care diagnostic system (Merlin) combining chemistry, hematology, and a proprietary silicon photonic microring resonator-based immunoassay platform (Maverick) for multiplexed, label-free detection of analytes from a single blood sample.

Genalyte competes with large central laboratory networks (Quest, LabCorp), traditional point-of-care analyzer companies (e.g., Abbott's i-STAT, Siemens Healthineers), and a new generation of decentralized testing startups. Its key differentiator is the combination of a broad test menu, full automation, and rapid turnaround in a single device, targeting to replace a segment of the send-out lab market directly at the point of care.